Rauf MS - Search Results

1

Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma.

Akhtar S, Rauf MS, Al-Kofide A, Elshenawy MA, Mushtaq AH, Maghfoor I. Akhtar S, et al. Among authors: rauf ms. Hered Cancer Clin Pract. 2021 Feb 9;19(1):17. doi: 10.1186/s13053-021-00175-0. Hered Cancer Clin Pract. 2021. PMID: 33563316 Free PMC article.

2

High-dose chemotherapy and auto-SCT for relapsed and refractory Hodgkin's lymphoma patients refractory to first-line salvage chemotherapy but responsive to second-line salvage chemotherapy.

Rauf MS, Maghfoor I, Elhassan TA, Akhtar S. Rauf MS, et al. Med Oncol. 2015 Jan;32(1):388. doi: 10.1007/s12032-014-0388-7. Epub 2014 Nov 28. Med Oncol. 2015. PMID: 25429839

3

Changing trends of adult lymphoma in the Kingdom of Saudi Arabia - comparison of data sources.

Rauf MS, Akhtar S, Maghfoor I. Rauf MS, et al. Asian Pac J Cancer Prev. 2015;16(5):2069-72. doi: 10.7314/apjcp.2015.16.5.2069. Asian Pac J Cancer Prev. 2015. PMID: 25773852 Free article.

4

High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma.

Akhtar S, Elhassan TAM, Edesa W, Rauf MS, Zahir MN, Maghfoor I. Akhtar S, et al. Among authors: rauf ms. Ann Hematol. 2016 Jan;95(1):49-54. doi: 10.1007/s00277-015-2527-4. Ann Hematol. 2016. PMID: 26467917

5

Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG.

Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, Ng AK, Roberts KB, Gao S, Balogh A, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis SA, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani RH, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT. Binkley MS, et al. Among authors: rauf ms. Blood. 2020 Jun 25;135(26):2365-2374. doi: 10.1182/blood.2019003877. Blood. 2020. PMID: 32211877 Free article.

6

Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer.

Elshenawy MA, Badran A, Aljubran A, Alzahrani A, Rauf MS, Eldali A, Bazarbashi S. Elshenawy MA, et al. Among authors: rauf ms. World J Surg Oncol. 2020 Jul 8;18(1):163. doi: 10.1186/s12957-020-01930-8. World J Surg Oncol. 2020. PMID: 32641137 Free PMC article. Clinical Trial.

7

Hodgkin lymphoma involving extranodal sites in head and neck: report of twenty-nine cases and review of three-hundred and fifty-seven cases.

Akhtar S, Khafaga Y, Edesa W, Al-Mubarak M, Rauf MS, Maghfoor I. Akhtar S, et al. Among authors: rauf ms. Hematology. 2021 Dec;26(1):103-110. doi: 10.1080/16078454.2020.1865667. Hematology. 2021. PMID: 33478377 Review.

8

Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East.

Akhtar S, Rauf MS, Khafaga Y, Al-Kofide A, Elhassan TAM, Elshenawy MA, Nadri J, Mushtaq AH, Bakshi N, Shamayel M, Al-Sweedan S, Sarwar S, Maghfoor I. Akhtar S, et al. Among authors: rauf ms. BMC Cancer. 2021 Apr 1;21(1):351. doi: 10.1186/s12885-021-08074-2. BMC Cancer. 2021. PMID: 33794818 Free PMC article.

9

Comparison of 18F-labelled fluoro-2-deoxyglucose-PET with conventional computed tomography for staging and response assessment in paediatric and adult patients with nodular lymphocyte-predominant Hodgkin's lymphoma.

Rauf MS, Khan ZA, Zahir MN, Al-Sweedan S, Al-Kofide A, Alharthy H, Almugbel FA, Osmani A, Elhassan TAM, Khafaga Y, Maghfoor I, Akhtar S. Rauf MS, et al. Nucl Med Commun. 2021 Aug 1;42(8):899-906. doi: 10.1097/MNM.0000000000001406. Nucl Med Commun. 2021. PMID: 33852535

10

Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience.

Osmani AH, Khafaga Y, Rauf MS, Maghfoor I, Akhtar S. Osmani AH, et al. Among authors: rauf ms. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):e149-e160. doi: 10.1016/j.clml.2021.09.003. Epub 2021 Sep 11. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34627735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page